PSVKX | WCMJX | PSVKX / WCMJX | |
Total Expense Ratio | 0.89 | 1.15 | 77% |
Annual Report Gross Expense Ratio | 34.41 | 1.70 | 2,024% |
Fund Existence | 8 years | 6 years | - |
Gain YTD | 9.268 | -3.056 | -303% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 377M | 51M | 739% |
Annual Yield % from dividends | 1.29 | 0.00 | - |
Returns for 1 year | -2.12 | -16.76 | 13% |
Returns for 3 years | 6.80 | 21.49 | 32% |
Returns for 5 years | 57.08 | 28.03 | 204% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RIBEX | 67.25 | 0.24 | +0.36% |
American Funds Invmt Co of Amer R2E | |||
KLCIX | 21.68 | N/A | N/A |
Federated Hermes Kaufmann Large Cap IS | |||
JFNCX | 61.87 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
SLLAX | 13.84 | N/A | N/A |
SEI Small Cap F (SIMT) | |||
JEVCX | 11.08 | N/A | N/A |
JHancock Disciplined Value Em Mkts Eq C |